Ameeta E Singh
Biographic Data
| ID | 5408575 |
|---|---|
| NAME | Ameeta E Singh |
| GIVEN NAMES | Ameeta E |
| FAMILY NAME | Singh |
| SIGNATURE | SINGH A E |
| AFFILIATIONS | University of Alberta |
| ORCID | 0000-0003-2627-3704 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 3 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2007 |
| LATEST PUBLICATION YEAR | 2018 |
| H-INDEX | 1 |
Housing interventions for homeless, pregnant/parenting women with addictions: A systematic review
Hughes Et Al. Respond
Siemieniuk et al. reported their experience with routine opt-out HIV screening in Southern Alberta, Canada, and the limitations of this approach. While we believe that routine opt-out testing has been a critical factor in reducing mother to child transmission (MTCT) of HIV in our region, we acknowledge that this approach does not eliminate the risk. Over the past 5 years (2004 to 2008 inclusive), approximately 3.5% of women have opted out of HIV …
Seroprevalence and Correlates of HIV and HCV among Injecting Drug Users in Edmonton, Alberta
Prenatal Screening and Perinatal HIV Transmission in Northern Alberta, 1999–2006
Objectives. We evaluated the effectiveness of a program that includes routine opt-out prenatal HIV screening, combination antiretroviral therapy (ART), and a multidisciplinary team in preventing perinatal HIV transmission. Methods. A retrospective analysis was performed on HIV-infected pregnant women in northern Alberta, Canada, who delivered between January 1, 1999, and February 28, 2006. Results. Ninety-eight women had 113 deliveries. Forty-thr…
The Feasibility of Using an ‘Opt-Out’ Approach to Achieve Universal HIV Testing of Tuberculosis Patients in Alberta
Outcomes from a Canadian Public Health Prenatal Screening Program for Hepatitis B: 1997–2004
Seroprevalence and Correlates of HIV and HCV among Injecting Drug Users in Edmonton, Alberta
Prenatal Screening and Perinatal HIV Transmission in Northern Alberta, 1999–2006
Objectives. We evaluated the effectiveness of a program that includes routine opt-out prenatal HIV screening, combination antiretroviral therapy (ART), and a multidisciplinary team in preventing perinatal HIV transmission. Methods. A retrospective analysis was performed on HIV-infected pregnant women in northern Alberta, Canada, who delivered between January 1, 1999, and February 28, 2006. Results. Ninety-eight women had 113 deliveries. Forty-thr…
The Feasibility of Using an ‘Opt-Out’ Approach to Achieve Universal HIV Testing of Tuberculosis Patients in Alberta
Outcomes from a Canadian Public Health Prenatal Screening Program for Hepatitis B: 1997–2004
Prenatal Screening and Perinatal HIV Transmission in Northern Alberta, 1999–2006
Objectives. We evaluated the effectiveness of a program that includes routine opt-out prenatal HIV screening, combination antiretroviral therapy (ART), and a multidisciplinary team in preventing perinatal HIV transmission. Methods. A retrospective analysis was performed on HIV-infected pregnant women in northern Alberta, Canada, who delivered between January 1, 1999, and February 28, 2006. Results. Ninety-eight women had 113 deliveries. Forty-thr…
The Feasibility of Using an ‘Opt-Out’ Approach to Achieve Universal HIV Testing of Tuberculosis Patients in Alberta
Hughes Et Al. Respond
Siemieniuk et al. reported their experience with routine opt-out HIV screening in Southern Alberta, Canada, and the limitations of this approach. While we believe that routine opt-out testing has been a critical factor in reducing mother to child transmission (MTCT) of HIV in our region, we acknowledge that this approach does not eliminate the risk. Over the past 5 years (2004 to 2008 inclusive), approximately 3.5% of women have opted out of HIV …
Seroprevalence and Correlates of HIV and HCV among Injecting Drug Users in Edmonton, Alberta
Housing interventions for homeless, pregnant/parenting women with addictions: A systematic review
Medicine (5 works) · HIV/AIDS Research and Interventions (4 works) · HIV, Drug Use, Sexual Risk (3 works) · Immunology (3 works) · Immunology (3 works) · Antibody (2 works) · Environmental health (2 works) · HIV/AIDS drug development and treatment (2 works) · Human immunodeficiency virus (HIV (2 works) · Internal Medicine (2 works)